A prospective single-center study to evaluate the feasibility of motivation management by wearable fitness devices and smart phone application to influence the clinical manifestation of non-alcoholic fatty liver disease (NAFLD) (OCUN-1) - Usefulness of motivation management for the clinical manifestation of NAFLD

Department of Hepatology, Graduate School of Medicine, Osaka City Universit.0 个研究点目标入组 50 人开始时间: 2019年2月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. HCV antibody and HBs antigen positive patients. 2. Patients who screened ANA, AMA-M2 antibody, IgG, IgM, etc. and autoimmune diseases (autoimmune hepatitis, primary biliary cholangitis, etc.) can not be excluded. 3. Patient with drug-induced liver injury. 4. Patients with metabolic liver disease (hemochromatosis, Wilson's disease, alpha-1 antitrypsin deficiency etc.) 5. Patients with severe heart disease (unstable angina, acute heart failure, severe valvular disease, severe arrhythmia, active myocarditis, moderate aortic aneurysm, severe hypertension and thrombophlebitis). 6. Patients with acute systemic disease or fever. 7. Patients with severe cirrhosis (Child-Pugh score B or C). 8. Patients with severe kidney disease (BUN 25 mg / dL or more or serum creatinine 2.0 mg / dL or more). 9. Patients who judged unsuitable as subjects by doctors.

发起方

Department of Hepatology, Graduate School of Medicine, Osaka City Universit.